Lawlis V Bryan
Director
2 companies
Insider Signal Score
53
AverageTrades Analyzed
7
12M Win Rate
42.9%
Avg 3M Return
+0.0%
Avg 12M Return
+2.3%
Lawlis V Bryan is a Director at BIOMARIN PHARMACEUTICAL INC with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $1.8M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | GERN Geron Corp | Director | Buy | 13,300 | $1.18 | $15,667.40 | New | +10.2% | +17.8% | |
| May 15, 2024 | GERN Geron Corp | Director | Sale+OE | 35,000 | $3.75 | $131,250.00 | -100% | +17.2% | -69.0% | |
| May 11, 2023 | GERN Geron Corp | Director | Sale+OE | 35,000 | $3.00 | $105,000.00 | -100% | +4.5% | +31.5% | |
| Apr 3, 2023 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 8,500 | $97.09 | $825,265.00 | -22.7% | -11.1% | -10.1% | |
| Apr 14, 2022 | BMRN Biomarin Pharmaceutical Inc | - | Sale+OE | 4,250 | $83.66 | $355,555.00 | -15.1% | +6.2% | +19.4% | |
| Jan 14, 2022 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 4,250 | $87.61 | $372,342.50 | -15.1% | -8.1% | +24.9% | |
| Apr 15, 2021 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 7,500 | $76.90 | $576,750.00 | -28.5% | +1.2% | +5.3% | |
| Feb 16, 2021 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 7,500 | $87.41 | $655,575.00 | -28.5% | - | - | |
| Jun 5, 2020 | BMRN Biomarin Pharmaceutical Inc | Director | Sell | 4,430 | $107.46 | $476,047.80 | -19.0% | - | - | |
| Mar 17, 2020 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 8,360 | $76.01 | $635,469.70 | -18.0% | - | - |
Page 1Next →